Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

American Capital Commits $212 Mln In One Stop Buyout Of Cambridge Major Labs

RELATED NEWS
Trade ACAS now with 

American Capital Ltd. (ACAS: Quote) announced that it has committed $212 million in the One Stop Buyout of Cambridge Major Laboratories, Inc. or , a global provider of complex chemistry-based outsourcing services to the pharmaceutical and biotechnology industries. CML expands American Capital's portfolio of healthcare products and services companies, which have aggregate revenues of over $600 million.

American Capital's investment took the form of debt and preferred and common equity.

In a separate press release, American Capital announced Thursday that in the fourth quarter of 2012, it made open market purchases of approximately 8.8 million shares of American Capital common stock, or 2.8% of the company's outstanding shares as of September 30, 2012. The shares were purchased at an average price of $11.72 per share, totaling approximately $103 million.

Click here to receive FREE breaking news email alerts for American Capital Ltd and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.